Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 14571413)

1.

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.

Becker JT, McNeel DG.

J Immunother Cancer. 2013 May 29;1:2. doi: 10.1186/2051-1426-1-2. eCollection 2013.

2.

DNA Vaccines for Prostate Cancer.

McNeel DG, Becker JT, Johnson LE, Olson BM.

Curr Cancer Ther Rev. 2012 Nov 1;8(4):254-263.

3.

Preclinical and clinical development of DNA vaccines for prostate cancer.

Teja Colluru V, Johnson LE, Olson BM, McNeel DG.

Urol Oncol. 2013 Dec 11. pii: S1078-1439(13)00387-6. doi: 10.1016/j.urolonc.2013.09.014. [Epub ahead of print]

PMID:
24332642
4.

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time.

Chudley L, McCann K, Mander A, Tjelle T, Campos-Perez J, Godeseth R, Creak A, Dobbyn J, Johnson B, Bass P, Heath C, Kerr P, Mathiesen I, Dearnaley D, Stevenson F, Ottensmeier C.

Cancer Immunol Immunother. 2012 Nov;61(11):2161-70. doi: 10.1007/s00262-012-1270-0. Epub 2012 May 22.

5.

Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.

Smith HA, McNeel DG.

J Immunother. 2011 Oct;34(8):569-80. doi: 10.1097/CJI.0b013e31822b5b1d.

6.

DNA vaccination: using the patient's immune system to overcome cancer.

Eschenburg G, Stermann A, Preissner R, Meyer HA, Lode HN.

Clin Dev Immunol. 2010;2010:169484. doi: 10.1155/2010/169484. Epub 2010 Dec 16. Review.

7.

DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.

Becker JT, Olson BM, Johnson LE, Davies JG, Dunphy EJ, McNeel DG.

J Immunother. 2010 Jul-Aug;33(6):639-47. doi: 10.1097/CJI.0b013e3181dda23e.

8.

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

McNeel DG, Dunphy EJ, Davies JG, Frye TP, Johnson LE, Staab MJ, Horvath DL, Straus J, Alberti D, Marnocha R, Liu G, Eickhoff JC, Wilding G.

J Clin Oncol. 2009 Sep 1;27(25):4047-54. doi: 10.1200/JCO.2008.19.9968. Epub 2009 Jul 27.

9.

Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma.

Liao JC, Gregor P, Wolchok JD, Orlandi F, Craft D, Leung C, Houghton AN, Bergman PJ.

Cancer Immun. 2006 Apr 21;6:8.

10.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk